| Dr Daniel J Brown, MD | |
|
300 Lackawanna Ave, Scranton, PA 18503-2001 | |
| (570) 342-7864 | |
| Not Available |
| Full Name | Dr Daniel J Brown |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 300 Lackawanna Ave, Scranton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417197708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD437196 (Pennsylvania) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD437196 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Regional Hospital Of Scranton | Scranton, PA | Hospital |
| Geisinger-community Medical Center | Scranton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has enrolled the first patient into the landmark KAST (Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) study. The case was performed by Sean Tutton, MD FSIR, Associate Professor of Radiology and Surgery at the Medical College of Wisconsin in Milwaukee.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.
The 1 percent tax will be imposed on all health-related insurance products sold in the nation's capital. Meanwhile, four more companies apply to sell insurance on the Washington state exchange and The Oregonian examines the reasons that state opted to participate in the federal insurance marketplace.
Amgen today announced that new data from a pivotal Phase 2 study evaluating BLINCYTO (blinatumomab) for the treatment of adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) was presented at the 56th American Society of Hematology Annual Meeting and Exposition.
› Verified 4 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has enrolled the first patient into the landmark KAST (Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) study. The case was performed by Sean Tutton, MD FSIR, Associate Professor of Radiology and Surgery at the Medical College of Wisconsin in Milwaukee.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.
The 1 percent tax will be imposed on all health-related insurance products sold in the nation's capital. Meanwhile, four more companies apply to sell insurance on the Washington state exchange and The Oregonian examines the reasons that state opted to participate in the federal insurance marketplace.
Amgen today announced that new data from a pivotal Phase 2 study evaluating BLINCYTO (blinatumomab) for the treatment of adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) was presented at the 56th American Society of Hematology Annual Meeting and Exposition.
› Verified 4 days ago
| Entity Name | Delta Medix Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396701876 PECOS PAC ID: 0648162636 Enrollment ID: O20040325001062 |
News Archive
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has enrolled the first patient into the landmark KAST (Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) study. The case was performed by Sean Tutton, MD FSIR, Associate Professor of Radiology and Surgery at the Medical College of Wisconsin in Milwaukee.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.
The 1 percent tax will be imposed on all health-related insurance products sold in the nation's capital. Meanwhile, four more companies apply to sell insurance on the Washington state exchange and The Oregonian examines the reasons that state opted to participate in the federal insurance marketplace.
Amgen today announced that new data from a pivotal Phase 2 study evaluating BLINCYTO (blinatumomab) for the treatment of adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) was presented at the 56th American Society of Hematology Annual Meeting and Exposition.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel J Brown, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Dr Daniel J Brown, MD 300 Lackawanna Ave, Scranton, PA 18503-2001 Ph: (570) 342-7864 |
News Archive
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has enrolled the first patient into the landmark KAST (Kiva® System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) study. The case was performed by Sean Tutton, MD FSIR, Associate Professor of Radiology and Surgery at the Medical College of Wisconsin in Milwaukee.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the fourth quarter and full year ended December 31, 2009.
The 1 percent tax will be imposed on all health-related insurance products sold in the nation's capital. Meanwhile, four more companies apply to sell insurance on the Washington state exchange and The Oregonian examines the reasons that state opted to participate in the federal insurance marketplace.
Amgen today announced that new data from a pivotal Phase 2 study evaluating BLINCYTO (blinatumomab) for the treatment of adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) was presented at the 56th American Society of Hematology Annual Meeting and Exposition.
› Verified 4 days ago
Dr. Ivan Cvorovic, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 501 S Washington Ave Ste 1000, Scranton, PA 18505 Phone: 570-343-2383 | |
Ritu Khurana, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 Mulberry St, Scranton, PA 18510 Phone: 570-703-7351 Fax: 570-703-7801 | |
Dr. Titilayo O Osuntokun, MD Pulmonary Disease Medicare: May Accept Medicare Assignments Practice Location: 959 Wyoming Ave, Scranton, PA 18509 Phone: 570-344-3517 Fax: 570-344-6839 | |
Nalini G Kakimallaiah, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 700 Quincy Ave, Hospitalist Office, Scranton, PA 18510 Phone: 866-519-0457 Fax: 570-770-5263 | |
Dr. Joseph Frank Leo, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 531 Mt Pleasant Dr, Scranton, PA 18503 Phone: 570-342-8500 Fax: 570-558-2290 | |
Fouzia Oza, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 700 Quincy Ave, Scranton, PA 18510 Phone: 570-770-5000 | |
John P Lundin, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 746 Jefferson Ave, Suite 305, Scranton, PA 18510 Phone: 570-342-1776 Fax: 570-963-0663 |